Name: Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders (en Inglés)
Price: 653752.00 COP
Availability: InStock
Author: Nussinovitch Udi
ISBN: 9780128137062

portada Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Nussinovitch Udi

Idioma

Inglés

N° páginas

553

Encuadernación

Tapa Dura

ISBN13

9780128137062

N° edición

Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders (en Inglés)

Nussinovitch Udi (Autor) · Academic Press · Tapa Dura

Libro Nuevo

$ 653.752

$ 1.089.587

Ahorras: $ 435.835

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 13 de Junio y el Viernes 21 de Junio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders (en Inglés)"

The increasing pace of advances in cardiology throughout the last few decades has fundamentally altered the natural course of heart patients. In the last few years, available therapies have been revolutionized completely by new transcatheter therapeutic approaches, novel ventricular assist devices, and new drugs. Also, molecular biology and genetics have a rapidly growing impact on cardiovascular diseases, enabling the field of regenerative medicine to become increasingly closer to routine clinical implementation. Emerging Technologies for Heart Diseases was conceived to cover the recent extensive literature on current and novel therapeutic options for cardiac patients. The first volume is dedicated to heart failure and valvular disorders, and the second covers myocardial ischemia and arrhythmias. The clinical topic is addressed in several chapters divided according to the therapeutic approach (mechanical or electrical device-based, or cell and gene-based). Each of the 46 chapters focuses on clinically available solutions, new therapies currently under evaluation in clinical trials, promising preclinical technologies, and emerging concepts and innovations that have not yet been tested in a preclinical model. Also, the book discusses future challenges and opportunities for clinical implementation. Lessons learned from abandoned experimental practices are also covered, giving the readers the widest possible perspective of current therapeutic dilemmas. Overall, this textbook was designed for physicians who want to stay up-to-date with current therapies and those of the future, for biomedical companies, and for those who wish to broaden their knowledge of new cardiovascular therapeutic options.